Lesión pulmonar aguda secundaria a transfusión (TRALI): reporte de un caso y revisión de la bibliografía
Main Article Content
Abstract
La lesión pulmonar aguda producida por transfusión (TRALI) es un grave síndrome clínico que se presenta con hipoxemia aguda y edema pulmonar no cardiogénico dentro de las 6 h de una transfusión con productos sanguíneos.
La incidencia reportada oscila entre 1 caso cada 5000 a 100000 trasfusiones.
Dos teorías han sido propuestas en su fisiopatología, una inmunomediada y otra no-inmune.
El diagnóstico es clínico, y el tratamiento es de sostén.
La mortalidad puede llegar al 10%, presentando elevada morbilidad.
Presentamos el caso de un paciente que cursando el postoperatorio inmediato de artrodesis posterior instrumentada por escoliosis, progresa con hipoxemia refractaria. Durante el acto quirúrgico requirió múltiples trasfusiones con hemoderivados por sangrado activo, por lo que se arriba al diagnóstico de TRALI. Requirió asistencia respiratoria mecánica con altos parámetros durante 72 h y sostén hemodinámico por bajo gasto cardíaco. Evoluciona favorablemente.
Article Details
The magazine does not retain the reproduction rights (copyright) so the authors can republish their works with the sole mention of the original publication source.
References
1-Vlaar A, Juffermans N. Transfusion-related acute lung injury: a clinical review. Lancet 2013 Sep 14; 382(9896):984-94.
2-Triulzi D. Transfusion-related acute lung injury: current concepts for the clinician. AnesthAnalg. 2009; 108: 770-776.
3-Moiz B, Sharif H, Bawany F. Transfusion related acute lung injury-TRALI: an under diagnosed entity. J Pak Med Assoc. 2009; 59: 39-41.
4-Gauvin F, Robillard P, Hume H et al. Transfusion-related acute lung injury in the Canadian paediatric population. Paediatr Child Health 2012; 17(5):235-240.
5- Lieberman L, Petraszko T, Yi QL et al. Transfusion-related lung injury in children: a case series and review of the literature. Transfusion. 2014 Jan;54(1):57-64.
6- PopovskyM ,Moore S. Diagnostic and pathogenetic considerations intransfusion-related acute lung injury. Transfusion.1985;25:573–7.
7- Silliman C, Thurman G, Ambruso D. Stored blood components contain agents that prime the neutrophil NADPH oxidase through theplatelet-activating-factorreceptor. Vox Sang. 1992;63:133–6.
8-Toy P,PopovskyM,AbrahamE et al. National Heart, Lung and Blood Institute working group on TRALI,Transfusion-relatedacute lung injury: Definition and review. Crit Care Med. 2005; 33: 721–6.
9- Bernard G, Artigas A, Brigham K et al. Report of the American-European consensus conference on ARDS: Definitions, mechanisms, relevant outcomes and clinical trial coordination.The Consensus Committee. Intensive Care Med.1994; 20:225–32.
10- Koussi A, Trachana M, Pliaki P et al. Transfusion related acute lung injury syndrome (TRALI) in a patient with thalassaemia. Pediatr Blood Cancer.2006; 46: 829-830.
11-Jawa R, Anillo S, Kulaylat M. Transfusion related acute lung injury. Intensive Care Med. 2008; 23: 109-121.
12- Boshkov L. Transfusion related acute lung injury and the ICU. Crit Care Clin.2005; 21:479–95.
13- Ferguson N, Fan E, Camporota L et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med (2012) 38:1573–1582.
14-Kopko P, Marshall C, MacKenzie M, et al. Transfusion-related acute lung injury report of a clinical look back investigation.JAMA.2002;287:1968–71.
15-Church G, Price C, Sanchez R et al. Transfusion-related acute lung injury in the paediatric patient: two case reports and a review of the literature. Transfusion Medicine, 2006, 16, 343–348.